Ninox Vision is set to transform diabetic retinopathy (DR) screening across Australia by scaling the Google Health-developed Automated Retinal Disease Assessment (ARDA) tool, an advanced AI diagnostic system proven to be superior for DR detection in real-world Australian trials.

Diabetic retinopathy is the leading cause of preventable vision loss among working-age Australians, yet current screening rates remain alarmingly low, particularly in regional and remote areas.

"Ninox Vision is poised to dramatically improve screening rates by making advanced, AI-driven retinal assessment accessible, efficient, and financially viable for primary care settings nationwide. Our mission is clear: to prevent vision loss and improve health outcomes for all Australians, especially those in underserved communities."

- Professor Angus Turner

Key Impacts of Ninox Vision

Prevents Vision Loss

Directly addresses a leading cause of preventable blindness.

Improves Health Equity

Significantly increases access to crucial screening, particularly for Aboriginal Australians who experience disproportionately higher rates of diabetes and related blindness.

Economic Benefits

Reduces healthcare costs associated with advanced DR, maintains workforce participation, and creates new jobs.

Digital Health Leadership

Positions Western Australia and Australia at the forefront of digital health innovation in eye care.

On the spot retinal diagnosis for primary care

Ninox AI will provide free integrated AI software to provide on the spot retinal diagnosis service to any primary care provider. This innovative system provides point-of-care diagnoses, requires minimal operator training, and seamlessly integrates into existing healthcare workflows, empowering local healthcare professionals to conduct vital screenings. The service is designed to be financially sustainable within primary care through existing Medicare rebates, making it an attractive and accessible solution.
Back to top
Image
Ninox AI is a social enterprise emerging from the Lions Eye Institute, dedicated to preventing blindness from diabetic retinopathy across Australia. Leveraging Google Health's advanced ARDA AI technology, Ninox AI supports a scalable, integrated, and financially sustainable retinal screening solution for primary care settings, aiming to significantly improve screening rates and health outcomes nationwide.
Image
The Lions Eye Institute is a world-renowned centre of excellence in ophthalmic research, education, and clinical care. For over 40 years, LEI has been at the forefront of preventing blindness and restoring sight, impacting countless lives through its groundbreaking work.

Contact Us

+61 422279179

info@ninoxvision.org

© 2025 Ninox Vision. All rights reserved.

Ninox Vision is not listed on the ARTG | For research use only.